These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25474456)

  • 21. Intravascular large B cell lymphoma: widespread but not everywhere.
    Ponzoni M; Ferreri AJ
    Acta Haematol; 2014; 131(1):16-7. PubMed ID: 24021531
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary pulmonary lymphoma: a case of 'unresolving pneumonia'.
    Cherian SV; Thampy E; Mauzo SH
    Am J Med; 2014 Mar; 127(3):e3-4. PubMed ID: 24365165
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 24. A male with primary breast lymphoma.
    Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M
    Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary bone lymphoma involving bilateral tibia.
    Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
    Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
    [No Abstract]   [Full Text] [Related]  

  • 27. Aggressive lymphoma involving intracranial epidural region.
    Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
    J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
    [No Abstract]   [Full Text] [Related]  

  • 28. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Testoni M; Kwee I; Greiner TC; Montes-Moreno S; Vose J; Chan WC; Chiappella A; Baldini L; Ferreri AJ; Gaidano G; Mian M; Zucca E; Bertoni F
    Br J Haematol; 2011 Oct; 155(2):274-7. PubMed ID: 21488860
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 31. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
    Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
    J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Standard or up-to-date treatment for high risk, relapsed and refractory DLBCL].
    Kagami Y
    Rinsho Ketsueki; 2010 Oct; 51(10):1409-16. PubMed ID: 20962474
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China.
    Wu YX; Liu B; Chen L; Li JH; Chen SQ
    Ann Hematol; 2013 Jun; 92(6):861-2. PubMed ID: 23238898
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 35. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA; McGratten M
    J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse prognosis of bulky disease in good-risk DLBCL.
    Ribera JM
    Lancet Oncol; 2008 May; 9(5):406-7. PubMed ID: 18452849
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma.
    Matsuo T; Tanaka T; Yano T
    J Clin Exp Hematop; 2018 Dec; 58(4):180-183. PubMed ID: 30416173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.